Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04231903
Other study ID # 0063123
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 1, 2014
Est. completion date December 31, 2018

Study information

Verified date January 2020
Source University of Turin, Italy
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Perfusion strategies and aortic clamping techniques for right mini-thoracotomy mitral valve (MV) surgery have evolved over time and remarkable short- and long-term results have been re-ported. However, some concerns have emerged about the adequacy of myocardial protection dur-ing the minimally invasive approach and about the role of aortic clamping strategies in this contest.

Aim of this study was to compare the efficacy, in terms of myocardial protection, of the en-do-aortic clamp (EAC) versus the trans-thoracic aortic clamp (TTC) in patients undergoing right mini-thoracotomy MV repair.

A single center, prospective observational study was performed between June 2014 to June 2018 on patients undergoing right mini-thoracotomy MV repair with retrograde arterial perfusion and EAC or TTC. The selection of one setting in respect to the other was patient orientated. Myocardial protection was assessed through creatinine kinase-myocardial band (CK-MB) and cardiac Troponin T (cTn-T) blood levels immediately after the surgical procedure and at 6, 12, and 24 hours and compared between the two groups.


Recruitment information / eligibility

Status Completed
Enrollment 116
Est. completion date December 31, 2018
Est. primary completion date June 30, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Surgical indication for mitral valve repair.

- Right mini-thoracotomy approach.

- Retrograde arterial perfusion.

Exclusion Criteria:

- Age more than 75 years.

- Cardiac ejection fraction lower than 40%.

- Previous cardiac surgery procedures for coronary artery bypass graft.

- Any degree of coronary artery disease.

- Severe peripheral vascular disease.

- Concomitant procedures for atrial fibrillation ablation.

Study Design


Intervention

Device:
Aortic clamp
In the firs group an endo-aortic clamp is used and in the second group an external clamp is used.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Turin, Italy

Outcome

Type Measure Description Time frame Safety issue
Primary cTn-T levels immediately after surgery Myocardial protection was assessed through cardiac Troponin T (cTn-T) blood levels and compared between the 2 groups of aortic clamping Immediately after surgery
Primary CK-MB levels immediately after surgery Myocardial protection was assessed through creatinine kinase-myocardial band (CK-MB) blood levels after right mini-thoracotomy mitral valve surgery and compared between the 2 groups of aortic clamping Immediately after the surgery
Primary cTn-T levels 6h Myocardial protection was assessed through cardiac Troponin T (cTn-T) blood levels and compared between the 2 groups of aortic clamping hour 6 after surgery
Primary CK-MB levels 6h Myocardial protection was assessed through creatinine kinase-myocardial band (CK-MB) blood levels after right mini-thoracotomy mitral valve surgery and compared between the 2 groups of aortic clamping hour 6 after surgery
Primary cTn-T levels 12h Myocardial protection was assessed through cardiac Troponin T (cTn-T) blood levels and compared between the 2 groups of aortic clamping hour 12 after surgery
Primary CK-MB levels 12h (CK-MB) blood levels after right mini-thoracotomy mitral valve surgery and compared between the 2 groups of aortic clamping hour 12 after surgery
Primary cTn-T levels 24h Myocardial protection was assessed through cardiac Troponin T (cTn-T) blood levels and compared between the 2 groups of aortic clamping hour 24 after surgery
Primary CK-MB levels 24h Myocardial protection was assessed through cardiac Troponin T (cTn-T) blood levels and compared between the 2 groups of aortic clamping hour 24 after surgery
See also
  Status Clinical Trial Phase
Not yet recruiting NCT02499419 - Exercise Capacity Evaluation in Patients With Non-rheumatic Mitral Valve Prolapse (MVP) N/A
Completed NCT02512341 - Automatic Differentiation of Innocent and Pathologic Murmurs in Pediatrics
Completed NCT02105480 - Automated Algorithm Based Analysis of Phonocardiograms of Newborns
Enrolling by invitation NCT04067635 - Primary Mitral Regurgitation Repair
Recruiting NCT06378996 - Arrhythmic Mitral Valve Prolapse Detection Using Long-term Ambulatory Rhythm Monitoring N/A
Terminated NCT03285724 - Safety and Performance Study of the Harpoon Mitral Valve Repair System N/A
Recruiting NCT03506217 - Using Pulse Counter Vigileo-Flotrac System in Transapical Off-pump Minimally Invasive Mitral Valve Repair
Completed NCT00665301 - Cardiac Output Pulmonary Arterial Catheter Compared to FloWaveâ„¢ 1000 N/A
Not yet recruiting NCT04299334 - Neochordae Technique in Mitral Valve Repair Phase 1
Completed NCT03470155 - Operative Mitral Valve Reconstruction in Functional mv Insufficiency With Reduced Systolic Ventricle Function
Recruiting NCT06341166 - Multiparametric SCores for Prediction of Myocardial fIbrosis in Patients With MITral vAlve pRolapse
Not yet recruiting NCT03609931 - Patient Specific Mitral Valve Modeling for Surgical Planning and Training
Recruiting NCT05631730 - Effect and Safety of Flecainide and Metoprolol Versus Metoprolol Alone to Suppress Ventricular Arrhythmias in Arrhythmic Mitral Valve Prolapse Phase 3
Recruiting NCT02552771 - The Canadian Mitral Research Alliance (CAMRA) Trial CardioLink-2 N/A
Recruiting NCT01719211 - Genetic Basis of Mitral Valve Prolapse
Recruiting NCT04190602 - Multicenter Post-Market Observational Registry of the NeoChord Artificial Chordae Delivery System
Recruiting NCT03113552 - Prognostic Impact of the Location of Mitral Valve Prolapse on the Long-term Results of Mitral Plasty
Recruiting NCT06255457 - Ventricular Arrhythmias in Patients Undergoing Mitral Valve Surgery
Completed NCT02771275 - Safety and Early Feasibility Study of the Harpoon Medical Device (EFS) N/A
Recruiting NCT05562804 - Mitral Valve Prolapse, Arrhythmias and Mitral Valve Surgery